dalcetrapib Advisory Board Meeting

  • calender Thursday, 19th November, 2020
  • clock 13:00h - 15:00h (UTC)

The objectives of the meeting are to:

• Discuss hypothesis of interaction between ADCY9, CETP and dalcetrapib
• Explore the patient journey and clinical implementation of pharmacogenomic precision medicine in CVD

The meeting will be chaired by Dr Marc Pfeffer from the Brigham and Women’s Hospital in Boston.

endorsement
Endorsement

This meeting is brought to you by COR2ED Medical Affairs & DalCor Pharmaceuticals

Other events of your interest

Cor2ed
Expert Knowledge Share Oncology
LUNG CONNECT cme
The evolving TROP2-directed ADC landscape in metastatic NSCLC and strategies to optimise the treatment experience

A virtual Experts Knowledge Share on the topic of ‘The evolving TROP2-directed ADC landscape in metastatic NSCLC and strategies to optimise the treatment experience’  with Scientific Committee Prof. Nicolas Girard…

  • calender 11th May, 2026
  • clock 16:30h - 17:45h UTC
Login
This event is supported by an Independent Educational Grant from AstraZeneca.
Cor2ed
The Role of PARPi in Prostate Cancer: Experts Knowledge Share

This Experts Knowledge Share meeting is chaired by an internationally renowned faculty in order to discuss the role of PARPi in prostate cancer.

  • calender 28th August, 2020
  • clock 16:30h - 18:00h UTC
Login
This Experts Knowledge Share is hosted by COR2ED. AstraZeneca has provided a sponsorship grant towards this independent programme

Stay tuned for new events

Stay updated!